- Home
- EXTR vs CRNX Comparison
EXTR vs CRNX Comparison
Compare EXTR & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXTR
- CRNX
- Stock Information
- Founded
- EXTR 1996
- CRNX 2008
- Country
- EXTR United States
- CRNX United States
- Employees
- EXTR N/A
- CRNX N/A
- Industry
- EXTR Telecommunications Equipment
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- EXTR Telecommunications
- CRNX Health Care
- Exchange
- EXTR Nasdaq
- CRNX Nasdaq
- Market Cap
- EXTR 2.8B
- CRNX 2.8B
- IPO Year
- EXTR 1999
- CRNX 2018
- Fundamental
- Price
- EXTR $20.77
- CRNX $42.32
- Analyst Decision
- EXTR Strong Buy
- CRNX Buy
- Analyst Count
- EXTR 6
- CRNX 12
- Target Price
- EXTR $21.42
- CRNX $74.45
- AVG Volume (30 Days)
- EXTR 1.9M
- CRNX 2.2M
- Earning Date
- EXTR 10-29-2025
- CRNX 11-06-2025
- Dividend Yield
- EXTR N/A
- CRNX N/A
- EPS Growth
- EXTR N/A
- CRNX N/A
- EPS
- EXTR N/A
- CRNX N/A
- Revenue
- EXTR $1,140,067,000.00
- CRNX $1,392,000.00
- Revenue This Year
- EXTR $10.26
- CRNX $428.87
- Revenue Next Year
- EXTR $7.48
- CRNX $958.11
- P/E Ratio
- EXTR N/A
- CRNX N/A
- Revenue Growth
- EXTR 2.05
- CRNX 0.51
- 52 Week Low
- EXTR $10.10
- CRNX $24.10
- 52 Week High
- EXTR $22.89
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- EXTR 50.54
- CRNX 57.33
- Support Level
- EXTR $19.32
- CRNX $43.72
- Resistance Level
- EXTR $21.15
- CRNX $45.95
- Average True Range (ATR)
- EXTR 0.70
- CRNX 1.96
- MACD
- EXTR -0.04
- CRNX -0.16
- Stochastic Oscillator
- EXTR 74.86
- CRNX 28.10
About EXTR Extreme Networks Inc.
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.